{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:36:08Z","timestamp":1783096568998,"version":"3.54.6"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004001","name":"Guizhou Province Science and Technology Foundation","doi-asserted-by":"publisher","award":["ZK (2023)319"],"award-info":[{"award-number":["ZK (2023)319"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.dmd.2026.100238","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:12:39Z","timestamp":1768867959000},"page":"100238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanism-based inactivation of CYP2C19 by bicuculline and related alteration in pharmacokinetics of clopidogrel"],"prefix":"10.1016","volume":"54","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-2147","authenticated-orcid":false,"given":"Jiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.dmd.2026.100238_bib1","first-page":"1541","article-title":"Anti-malarial activity of isoquinoline alkaloids from the stem bark of Actinodaphne macrophylla","volume":"10","author":"Fadaeinasab","year":"2015","journal-title":"Nat Prod Commun"},{"key":"10.1016\/j.dmd.2026.100238_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jchromb.2013.11.010","article-title":"A HPLC\u2013MS\/MS method for the simultaneous quantitation of six alkaloids of rhizoma corydalis decumbentis in rat plasma and its application to a pharmacokinetic study","volume":"944","author":"Liao","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.dmd.2026.100238_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fphar.2019.00132","article-title":"Bicuculline reduces neuroinflammation in hippocampus and improves spatial learning and anxiety in hyperammonemic rats. Role of glutamate receptors","volume":"10","author":"Malaguarnera","year":"2019","journal-title":"Front Pharmacol"},{"issue":"15","key":"10.1016\/j.dmd.2026.100238_bib4","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1002\/jssc.202200259","volume":"45","author":"Wu","year":"2022","journal-title":"J Sep Sci"},{"issue":"9","key":"10.1016\/j.dmd.2026.100238_bib5","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1039\/C7NP00034K","article-title":"Cytochromes P450 for natural product biosynthesis in streptomyces: sequence, structure, and function","volume":"34","author":"Rudolf","year":"2017","journal-title":"Nat Prod Rep"},{"issue":"7","key":"10.1016\/j.dmd.2026.100238_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2217\/pgs-2017-0194","article-title":"Pharmacogenetics of drug\u2013drug interaction and drug\u2013drug\u2013gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6","volume":"18","author":"Bahar","year":"2017","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.dmd.2026.100238_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.dmd.2026.100238_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1326776","article-title":"From genes to drugs: CYP2C19 and pharmacogenetics in clinical practice","volume":"15","author":"Shubbar","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.dmd.2026.100238_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109147","article-title":"Evaluation of acacetin inhibition potential against cytochrome P450 in vitro and in vivo","volume":"329","author":"Zhou","year":"2020","journal-title":"Chem Biol Interact"},{"issue":"2","key":"10.1016\/j.dmd.2026.100238_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22251","article-title":"Mechanism-based inactivation of cytochrome P450 2D6 by chelidonine","volume":"33","author":"Liu","year":"2019","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"10.1016\/j.dmd.2026.100238_bib11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ptr.3255","article-title":"Identification of cytochrome P450 (CYP) isoforms involved in the metabolism of corynoline, and assessment of its herb\u2013drug interactions","volume":"25","author":"Fang","year":"2011","journal-title":"Phytother Res"},{"issue":"12","key":"10.1016\/j.dmd.2026.100238_bib12","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1124\/dmd.111.041319","article-title":"CYP2C19 progress curve analysis and mechanism-based inactivation by three methylenedioxyphenyl compounds","volume":"39","author":"Salminen","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.dmd.2026.100238_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1389200054021799","article-title":"A comprehensive listing of bioactivation pathways of organic functional groups","volume":"6","author":"Kalgutkar","year":"2005","journal-title":"Curr Drug Metab"},{"issue":"5","key":"10.1016\/j.dmd.2026.100238_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/10408440701215233","article-title":"Toxicological significance of mechanism-based inactivation of cytochrome P450 enzymes by drugs","volume":"37","author":"Masubuchi","year":"2007","journal-title":"Crit Rev Toxicol"},{"issue":"2","key":"10.1016\/j.dmd.2026.100238_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pharmthera.2009.10.008","article-title":"Impact of genetic and acquired alteration in cytochrome P450 system on pharmacologic and clinical response to clopidogrel","volume":"125","author":"Ma","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.dmd.2026.100238_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3390\/pharmaceutics16050685","article-title":"Integrating clopidogrel\u2019s first-pass effect in a joint semi-physiological population pharmacokinetic model of the drug and its inactive carboxylic acid metabolite","volume":"16","author":"Pej\u010di\u0107","year":"2024","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.dmd.2026.100238_bib17","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/ptr.5691","article-title":"Effect of ginkgo biloba extract on the pharmacokinetics and metabolism of clopidogrel in rats","volume":"30","author":"Deng","year":"2016","journal-title":"Phytother Res"},{"issue":"6","key":"10.1016\/j.dmd.2026.100238_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/1755-5922.12028","article-title":"Epidemiology of CYP 3A4-mediated clopidogrel drug\u2013drug interactions and their clinical consequences","volume":"31","author":"Tirkkonen","year":"2013","journal-title":"Cardiovasc Ther"},{"issue":"8","key":"10.1016\/j.dmd.2026.100238_bib19","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/jcph.337","article-title":"Clopidogrel, CYP2C19 and proton pump inhibitors: what we know and what it means","volume":"54","author":"Hariharan","year":"2014","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.dmd.2026.100238_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40256-016-0172-5","article-title":"Drug interaction between clopidogrel and ranitidine or omeprazole in stable coronary artery disease: a double-blind, double dummy, randomized study","volume":"16","author":"Furtado","year":"2016","journal-title":"Am J Cardiovasc Drugs"},{"issue":"6","key":"10.1016\/j.dmd.2026.100238_bib21","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1111\/jvim.17198","article-title":"The effect of concurrent clopidogrel and omeprazole administration on clopidogrel metabolism and platelet function in healthy cats","volume":"38","author":"Plante","year":"2024","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.dmd.2026.100238_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112278","article-title":"Mechanistic study of bergamottin-induced inactivation of CYP2C9","volume":"153","author":"Liu","year":"2021","journal-title":"Food Chem Toxicol"},{"issue":"11","key":"10.1016\/j.dmd.2026.100238_bib23","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/00498254.2021.1913666","article-title":"Metabolic activation of aegeline mediated by CYP2C19","volume":"51","author":"Tian","year":"2021","journal-title":"Xenobiotica"},{"issue":"6","key":"10.1016\/j.dmd.2026.100238_bib24","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1124\/dmd.110.037531","article-title":"Metabolic intermediate complex formation of human cytochrome P450 3A4 by lapatinib","volume":"39","author":"Takakusa","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2026.100238_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/03602532.2014.1003648","article-title":"Mechanism-based inactivation of CYP450 enzymes: a case study of lapatinib","volume":"47","author":"Ho","year":"2015","journal-title":"Drug Metab Rev"},{"issue":"2","key":"10.1016\/j.dmd.2026.100238_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1357-2725(00)00076-5","article-title":"Kinetic analysis of enzyme systems with suicide substrate in the presence of a reversible competitive inhibitor, tested by simulated progress curves","volume":"33","author":"Moruno-D\u00e1vila","year":"2001","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100238_bib27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/dmd.109.029132","article-title":"Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite","volume":"38","author":"Kazui","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"16","key":"10.1016\/j.dmd.2026.100238_bib28","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2010.1543","article-title":"Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis","volume":"304","author":"Mega","year":"2010","journal-title":"JAMA"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:26:54Z","timestamp":1776180414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0090955626000073"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100238","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism-based inactivation of CYP2C19 by bicuculline and related alteration in pharmacokinetics of clopidogrel","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100238"}}